Evaluation of Ergocalciferol or Cholecalciferol Dosing, 1,600 IU Daily or 50,000 IU Monthly in Older Adults | Zendy

Neil Binkley | Zendy; Dessa Gemar | Zendy; J. Engelke | Zendy; Ronald E. Gang | Zendy; Rekha Ramamurthy | Zendy; Diane Krueger | Zendy; M. K. Drezner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of Ergocalciferol or Cholecalciferol Dosing, 1,600 IU Daily or 50,000 IU Monthly in Older Adults

Author(s) -

Neil Binkley,

Dessa Gemar,

J. Engelke,

Ronald E. Gang,

Rekha Ramamurthy,

Diane Krueger,

M. K. Drezner

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2010-0015

Subject(s) - ergocalciferol , cholecalciferol , vitamin d and neurology , medicine , endocrinology , dosing , parathyroid hormone , calcium , urine , vitamin d deficiency , urinary calcium , n terminal telopeptide , alkaline phosphatase , chemistry , osteocalcin , biochemistry , enzyme

Whether ergocalciferol (D(2)) and cholecalciferol (D(3)) are equally effective to increase and maintain serum 25-hydroxyvitamin D [25(OH)D] concentration is controversial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research